Welcome to our dedicated page for Purple Innovation SEC filings (Ticker: PRPL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Purple Innovation's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Purple Innovation's regulatory disclosures and financial reporting.
Purple Innovation, Inc. furnished an 8‑K to announce it issued a press release with financial results for the third quarter ended September 30, 2025. The press release is attached as Exhibit 99.1.
The company stated the information under Item 2.02, including Exhibit 99.1, is furnished and not deemed filed under the Exchange Act. The release includes non‑GAAP financial measures, with reconciliations to the most comparable GAAP figures provided in the press release.
Purple Innovation, Inc. (PRPL) filed its Q3 2025 10‑Q, showing steady revenue and a smaller operating loss versus last year. Revenue was $118,766, with gross profit of $50,851 and an operating loss of $12,126 compared with a $46,813 loss a year ago. Net loss was $11,720 (basic and diluted loss per share $0.11).
Channel mix reflected a balanced model: wholesale $51,541, e‑commerce $45,275, and showrooms $21,950. Cash and cash equivalents were $32,358 as of September 30, 2025, and the company reported a stockholders’ deficit of $(26,939). Related party debt (net of issuance costs) was $102,889, with interest largely paid‑in‑kind year‑to‑date.
The company continued executing its 2024 restructuring, cumulatively recognizing $48,779 in restructuring, impairment, and related charges through Q3 2025, while noting cost actions and supply chain initiatives. A commercial update with Mattress Firm (SGI) expands product placement from ~5,000 to at least 12,000 mattress slots. Management concluded it has sufficient liquidity for at least one year from issuance.
SomniGroup International Inc. filed a Schedule 13G reporting beneficial ownership of 8,000,000 shares of Purple Innovation, Inc. Class A common stock, representing 6.88% of the class. The filing states these 8,000,000 shares "could be acquired" upon exercise of warrants at an exercise price of $1.50 per share, subject to adjustment. The percent calculation is based on 108,243,946 Class A shares outstanding as reported by the issuer on July 28, 2025. SomniGroup reports sole voting and dispositive power over the 8,000,000 shares and certifies the holdings were not acquired to influence control.
On August 7, 2025, Purple Innovation, Inc. amended two executive compensation arrangements. The company executed an amendment to Robert T. DeMartini’s Amended and Restated Employment Agreement to revise the definition of a change in control. On the same date the Board approved an amendment to the form Restricted Share Unit (RSU) Agreement for selected senior leaders that provides 100% vesting of each participant’s RSUs if the company terminates the participant’s employment without cause and likewise revises the change-in-control definition.
The filings incorporate the full amendment texts as Exhibits 10.1 and 10.2 and include the Inline XBRL cover page as Exhibit 104. Named officers referenced include Todd Vogensen, John J. Roddy, and Eric S. Haynor. The summaries reported here are qualified in their entirety by the filed exhibits.